GH Research (GHRS) Stock Forecast & Price Target

Compare

308 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GHRS Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Research

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GHRS Stock 12 Month Forecast

Average Price Target

$30.20

▲(94.21% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for GH Research in the last 3 months. The average price target is $30.20 with a high forecast of $39.00 and a low forecast of $19.00. The average price target represents a 94.21% change from the last price of $15.55.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","23":"$23","40":"$40","14.5":"$14.5","31.5":"$31.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":39,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$39.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$19.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,14.5,23,31.5,40],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.7,14.723076923076922,16.746153846153845,18.769230769230766,20.79230769230769,22.815384615384616,24.838461538461537,26.86153846153846,28.884615384615383,30.907692307692304,32.93076923076923,34.95384615384616,36.97692307692307,{"y":39,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.7,14.046153846153846,15.392307692307693,16.738461538461536,18.084615384615383,19.43076923076923,20.776923076923076,22.123076923076923,23.46923076923077,24.815384615384616,26.161538461538463,27.50769230769231,28.853846153846153,{"y":30.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.7,13.184615384615384,13.669230769230769,14.153846153846153,14.638461538461538,15.123076923076923,15.607692307692307,16.092307692307692,16.576923076923077,17.06153846153846,17.546153846153846,18.03076923076923,18.515384615384615,{"y":19,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.6,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.13,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.77,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.93,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.57,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.32,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.21,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$39.00

Average Price Target$30.20

Lowest Price Target$19.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ami Fadia

Needham

$19

Buy

22.19%

Upside

Reiterated

01/06/26

GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating

Patrick Trucchio

H.C. Wainwright

$35

Buy

125.08%

Upside

Reiterated

01/05/26

GH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating

Sumant Kulkarni

Canaccord Genuity

$35→$39

Buy

150.80%

Upside

Reiterated

01/05/26

GH Research price target raised to $39 from $35 at CanaccordGH Research price target raised to $39 from $35 at Canaccord

Brian Abrahams

RBC Capital

$29→$33

Buy

112.22%

Upside

Reiterated

01/05/26

RBC Capital Sticks to Their Buy Rating for GH Research (GHRS)

Ritu Baral

TD Cowen

Buy

―

Reiterated

11/10/25

GH Research: Proactive Regulatory Engagement and Strong Financial Positioning Support Buy Rating

Joshua Schimmer

Cantor Fitzgerald

$25

Buy

60.77%

Upside

Reiterated

11/06/25

Cantor Fitzgerald Keeps Their Buy Rating on GH Research (GHRS)

Eddie Hickman

Guggenheim

$29

Buy

86.50%

Upside

Reiterated

08/07/25

Guggenheim Remains a Buy on GH Research (GHRS)

Paul Matteis

Stifel Nicolaus

$32

Buy

105.79%

Upside

Reiterated

07/28/25

GH Research (GHRS) Gets a Buy from Stifel Nicolaus

Jason Butler

Citizens JMP

$39

Buy

150.80%

Upside

Reiterated

07/24/25

GH Research (GHRS) Receives a Buy from Citizens JMP

Elemer Piros

Lucid Capital

$42→$36

Buy

131.51%

Upside

Reiterated

02/07/25

GH Research PLC (GHRS) PT Lowered to $36 at Rodman RenshawRodman Renshaw analyst Elemer Piros lowered the price target on GH Research PLC (NASDAQ: GHRS) to $36.00 (from $42.00) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ami Fadia

Needham

$19

Buy

22.19%

Upside

Reiterated

01/06/26

GH Research: FDA Lifts Clinical Hold on GH001, Clearing Path to Phase 3 and Supporting Buy Rating

Patrick Trucchio

H.C. Wainwright

$35

Buy

125.08%

Upside

Reiterated

01/05/26

GH Research: Pivotal Pathway for GH001 in Treatment-Resistant Depression Supports $35 Target and Reiterated Buy Rating

Sumant Kulkarni

Canaccord Genuity

$35→$39

Buy

150.80%

Upside

Reiterated

01/05/26

GH Research price target raised to $39 from $35 at CanaccordGH Research price target raised to $39 from $35 at Canaccord

Brian Abrahams

RBC Capital

$29→$33

Buy

112.22%

Upside

Reiterated

01/05/26

RBC Capital Sticks to Their Buy Rating for GH Research (GHRS)

Ritu Baral

TD Cowen

Buy

―

Reiterated

11/10/25

GH Research: Proactive Regulatory Engagement and Strong Financial Positioning Support Buy Rating

Joshua Schimmer

Cantor Fitzgerald

$25

Buy

60.77%

Upside

Reiterated

11/06/25

Cantor Fitzgerald Keeps Their Buy Rating on GH Research (GHRS)

Eddie Hickman

Guggenheim

$29

Buy

86.50%

Upside

Reiterated

08/07/25

Guggenheim Remains a Buy on GH Research (GHRS)

Paul Matteis

Stifel Nicolaus

$32

Buy

105.79%

Upside

Reiterated

07/28/25

GH Research (GHRS) Gets a Buy from Stifel Nicolaus

Jason Butler

Citizens JMP

$39

Buy

150.80%

Upside

Reiterated

07/24/25

GH Research (GHRS) Receives a Buy from Citizens JMP

Elemer Piros

Lucid Capital

$42→$36

Buy

131.51%

Upside

Reiterated

02/07/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GH Research

3 Months

xxx

Success Rate

9/14 ratings generated profit

Average Return

+1.89%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +1.89% per trade.

1 Year

Patrick TrucchioH.C. Wainwright

Success Rate

19/22 ratings generated profit

Average Return

+22.62%

reiterated a buy rating 8 days ago

Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 86.36% of your transactions generating a profit, with an average return of +22.62% per trade.

2 Years

xxx

Success Rate

21/22 ratings generated profit

Average Return

+41.64%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +41.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GHRS Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GHRS has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GHRS average Analyst price target in the past 3 months is 30.20.

Each month's total comprises the sum of three months' worth of ratings.

GHRS Financial Forecast

GHRS Earnings Forecast

Next quarter’s earnings estimate for GHRS is -$0.27 with a range of -$0.35 to -$0.20. The previous quarter’s EPS was -$0.23. GHRS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GHRS has Performed in-line its overall industry.

No data currently available

GHRS Sales Forecast

Next quarter’s sales forecast for GHRS is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. GHRS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GHRS has Performed in-line its overall industry.

GHRS Stock Forecast FAQ

What is GHRS’s average 12-month price target, according to analysts?

Based on analyst ratings, GH Research’s 12-month average price target is 30.20.

What is GHRS’s upside potential, based on the analysts’ average price target?

GH Research has 94.21% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GHRS a Buy, Sell or Hold?

GH Research has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is GH Research’s price target?

The average price target for GH Research is 30.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.00 ,the lowest forecast is $19.00. The average price target represents 94.21% Increase from the current price of $15.55.

What do analysts say about GH Research?

GH Research’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of GHRS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

GH Research (GHRS) Stock Forecast & Price Target

GHRS Analyst Ratings

GHRS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GH Research

GHRS Analyst Recommendation Trends

GHRS Financial Forecast

GHRS Earnings Forecast

GHRS Sales Forecast

GHRS Stock Forecast FAQ

Detailed List of Analyst Forecasts